Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Amifostine provides additional protection
of salivary gland function over that achieved with IMRT alone.